April 22, 2017 by Brian Bossetta
Atul Kavthekar, Diplomat Pharmacy, Phil Hagerman, specialty pharmacies
2017, Issue 04-24-2017, Issues, News
FLINT, Mich. — Starting May 1, one of the leading independent specialty pharmacies will have a new chief financial officer. Diplomat Pharmacy recently announced the appointment of Atul Kavthekar as CFO and treasurer. Kavthekar, according to Diplomat, has demonstrated financial and strategic leadership in his previous roles in the technology, health care and investment banking
April 22, 2017 by Chain Drug Review
DIR fees, direct and indirect remuneration fees, H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Drug Spending Act, National Community Pharmacists Association, NCPA, retroactive pharmacy DIRs, S. 413
2017, Issue 04-24-2017, Issues, News
ALEXANDRIA, Va. — A group 118 health care stakeholders, including chain drug retailers, have called on Congress to crack down on direct and indirect remuneration (DIR) fees in Medicare Part D. Mobilized by the National Community Pharmacists Association (NCPA), the broad coalition sent letters to the Senate and House of Representatives to voice their support
April 22, 2017 by Greg Jacobson and Chain Drug Review
Alex Katen, AllianceRx Walgreens Prime, Daniel Tardiff, Don Vidic, Guillermo Sollberger, Jim Adams, Jim DuCharme, Joel Wright, Prime Therapeutics, Walgreens, Walgreens Boots Alliance
2017, Issue 04-24-2017, Issues, News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. (WBA) and Prime Therapeutics LLC have completed the formation of a combined central specialty pharmacy and mail service company, a move that was first announced last August. The leadership team of the new enterprise, AllianceRx Walgreens Prime, has also been revealed. Joel Wright, formerly divisional vice president for
April 22, 2017 by Geoff Walden and Chain Drug Review
HealthWatch for Business, Mark Rolnick, Shoppers Drug Mart
2017, Issue 04-24-2017, Issues, News
TORONTO — Shoppers Drug Mart (SDM) is launching a drug plan focused on better managing chronic conditions to help companies and their employees save 5% to 10% on their existing plan. The HealthWATCH for Business plan will integrate with Canadian employers’ current health coverage. “We understand that employers are facing unprecedented financial pressures due to
April 22, 2017 by Mark Baumgartner and Chain Drug Review
Alex Perez-Tenessa, Alicia Yoon, CVS Pharmacy, K-Beauty cosmetics, K-Beauty HQ, Korean beauty
2017, Issue 04-24-2017, Issues, News
WOONSOCKET, R.I. — CVS Pharmacy this month is introducing beauty boutiques in 2,100 of its stores, featuring more than 100 new products from South Korea, many exclusive to CVS. The K-Beauty HQ boutiques will feature a collection of beauty brands curated by Alicia Yoon, a trailblazer in the K-Beauty cosmetics and skin care trend that
April 22, 2017 by Greg Jacobson and Chain Drug Review
Alex Gourlay, Beauty Differentiation, George Fairweather, No7, Soap & Glory, Stefano Pessina, Walgreens, Walgreens Boots Alliance
2017, Issue 04-24-2017, Issues, News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. (WBA) is reaping success with its beauty differentiation program and is now planning to expand the initiative to more than 1,000 additional Walgreens stores by the end of 2017 while introducing more exclusive brands into the assortment. The first phase of the Walgreens beauty differentiation program’s rollout called
April 22, 2017 by Scot Meyer and Chain Drug Review
credit card industry, credit card swipe fees, Mallory Duncan, MasterCard, National Retail Federation, retail industry, Supreme Court, Visa
2017, Issue 04-24-2017, Issues, News
WASHINGTON — Two recent Supreme Court decisions offered good news to retailers regarding their ongoing fight over the fees they pay on credit and debit card transactions. Late last month the Supreme Court declined to hear an appeal that sought to reinstate a $7.25 billion antitrust settlement of price-fixing charges against MasterCard Inc. and Visa
April 22, 2017 by Greg Jacobson and Chain Drug Review
Alliance Healthcare, Alphega Pharmacy, Ornella Barra, Walgreens Boots Alliance
2017, Issue 04-24-2017, Issues, News
MONTE CARLO, Monaco — The Alphega Pharmacy network, part of the Alliance Healthcare arm of Walgreens Boots Alliance Inc. (WBA), recently held its eighth European convention here, attracting more than 1,200 attendees from nine different countries. Based on the theme “Close to You,” the gathering featured presentations on health care innovation, global market developments and
April 22, 2017 by Wendy Liebmann and Chain Drug Review
chain drug retailers, drug store shopper, How America Shops, Wendy Liebmann, WSL Strategic Retail
2017, Issue 04-24-2017, Issues, Leading Headlines, Opinion
If you do business in the drug channel, the question of what happened to drug store traffic over the last few months is one I’m sure you’ve been seriously puzzling over. That and several others: Was it an aberration? When will traffic return? Will it return? Why did it happen? And, oh yes, how should
April 22, 2017 by David Pinto and Chain Drug Review
2017 NACDS Annual Meeting, chain drug industry, chain drug retailers, David Pinto, drug store sales
2017, Issue 04-24-2017, Issues, Opinion
New formats are popping up throughout the chain drug industry, as retailers seek to overcome the sales malaise that has ensnared the industry this year. To recapture lost momentum, chain drug retailers are testing new store sizes, new merchandise assortments, new product locations within stores and new store concepts, sometimes all at once. It’s far
April 22, 2017 by Geoff Walden and Chain Drug Review
2017, Business, Featured Articles, Issue 04-24-2017, Issues, Leading Headlines, News, Retail News
NEW YORK — These are uncertain times for chain drug stores. The turbulent political atmosphere surrounding the Affordable Care Act, combined with the undetermined outcome of Walgreens Boots Alliance Inc.’s (WBA’s) acquisition of Rite Aid Corp., is making 2017 one of the more unsettled years for the industry in recent memory. The ACA “is in
April 22, 2017 by Jeffrey Woldt and Chain Drug Review
Affordable Care Act, CVS Health, Jeffrey Woldt, Larry Merlo, Medicaid reimbursements, National Association of Chain Drug Stores, National Community Pharmacists Association, Tom Moriarty
2017, Issue 04-24-2017, Issues, Opinion
CVS Health earlier this month named Tom Moriarty to the new position of chief policy and external affairs officer. As explained by president and chief executive officer Larry Merlo, the rationale behind the creation of the role is to “deliver an integrated approach to policy development and external engagement so the company can contribute to